Literature DB >> 33726818

Secreted factors from dental pulp stem cells improve Sjögren's syndrome via regulatory T cell-mediated immunosuppression.

Mayu Matsumura-Kawashima1, Kenichi Ogata2, Masafumi Moriyama1, Yuka Murakami1, Tatsuya Kawado1, Seiji Nakamura1.   

Abstract

BACKGROUND: Sjögren's syndrome (SS) is a chronic autoimmune disease primarily characterized by inflammation in the salivary and lacrimal glands. Activated T cells contribute to disease pathogenesis by producing proinflammatory cytokines, which leads to a positive feedback loop establishment. The study aimed to evaluate the effects of secreted factors derived from dental pulp stem cells (DPSCs) or bone marrow mesenchymal stem cells (BMMSCs) on hyposalivation in SS and to investigate the mechanism involved.
METHODS: Eighty percent confluent stem cells were replenished with serum-free Dulbecco's modified Eagle's medium and incubated for 48 h; following which, conditioned media from DPSCs (DPSC-CM) and BMMSCs (BMMSC-CM) were collected. Cytokine array analysis was performed to assess the types of cytokines present in the media. Flow cytometric analysis was performed to evaluate the number of activated T cells cultured in DPSC-CM or BMMSC-CM. Subsequently, DPSC-CM or BMMSC-CM was administered to an SS mouse model. The mice were categorized into the following groups (n = 6 each): non-treatment, Dulbecco's modified Eagle's medium (-), BMMSC-CM, and DPSC-CM. Histological analysis of the salivary glands was performed. The gene and protein expression levels of cytokines associated with T helper subsets in the submandibular glands (SMGs) were evaluated.
RESULTS: DPSC-CM contained more secreted factors with tissue-regenerating mechanisms, such as cell proliferation, anti-inflammatory effects, and immunomodulatory effects. DPSC-CM was more effective in suppressing the activated T cells than other groups in the flow cytometric analysis. The stimulated salivary flow rate increased in SS mice with DPSC-CM compared with that in the other groups. In addition, the number of inflammation sites in SMGs of the mice administered with DPSC-CM was lower than that in the other groups. The expression levels of interleukin (Il)-10 and transforming growth factor-β1 were upregulated in the DPSC-CM group, whereas those of Il-4 and Il-17a were downregulated. The DPSC-CM-administered group presented with a significantly increased percentage of regulatory T (Treg) cells and a significantly decreased percentage of type 17 Th (Th17) cells compared with the other groups.
CONCLUSIONS: These results indicated that DPSC-CM ameliorated SS by promoting Treg cell differentiation and inhibiting Th17 cell differentiation in the mouse spleen.

Entities:  

Keywords:  Dental pulp stem cell; Regulatory T cell; Secreted factor; Sjögren’s syndrome

Year:  2021        PMID: 33726818      PMCID: PMC7962357          DOI: 10.1186/s13287-021-02236-6

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  66 in total

1.  Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.

Authors:  J Brayer; J Lowry; S Cha; C P Robinson; S Yamachika; A B Peck; M G Humphreys-Beher
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

2.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.

Authors:  Martin Vaeth; Ulrike Schliesser; Gerd Müller; Sonja Reissig; Kazuki Satoh; Andrea Tuettenberg; Helmut Jonuleit; Ari Waisman; Martin R Müller; Edgar Serfling; Birgit S Sawitzki; Friederike Berberich-Siebelt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

4.  Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model.

Authors:  Kenichi Ogata; Wataru Katagiri; Masashi Osugi; Takamasa Kawai; Yukiko Sugimura; Hideharu Hibi; Seiji Nakamura; Minoru Ueda
Journal:  Bone       Date:  2015-01-19       Impact factor: 4.398

Review 5.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

Review 6.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

7.  Peripheral Nerve Regeneration by Secretomes of Stem Cells from Human Exfoliated Deciduous Teeth.

Authors:  Yukiko Sugimura-Wakayama; Wataru Katagiri; Masashi Osugi; Takamasa Kawai; Kenichi Ogata; Kohei Sakaguchi; Hideharu Hibi
Journal:  Stem Cells Dev       Date:  2015-08-10       Impact factor: 3.272

8.  Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.

Authors:  Junji Xu; Dandan Wang; Dayong Liu; Zhipeng Fan; Huayong Zhang; Ousheng Liu; Gang Ding; Runtao Gao; Chunmei Zhang; Yaozhong Ding; Jonathan S Bromberg; Wanjun Chen; Lingyun Sun; Songlin Wang
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

9.  RORγt antagonist improves Sjögren's syndrome-like sialadenitis through downregulation of CD25.

Authors:  Yuko Ono; Hiroto Tsuboi; Masafumi Moriyama; Hiromitsu Asashima; Hanae Kudo; Hiroyuki Takahashi; Fumika Honda; Saori Abe; Yuya Kondo; Satoru Takahashi; Isao Matsumoto; Seiji Nakamura; Takayuki Sumida
Journal:  Oral Dis       Date:  2020-03-03       Impact factor: 3.511

10.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

View more
  7 in total

Review 1.  The Therapeutic Potential of Secreted Factors from Dental Pulp Stem Cells for Various Diseases.

Authors:  Kenichi Ogata; Masafumi Moriyama; Mayu Matsumura-Kawashima; Tatsuya Kawado; Aiko Yano; Seiji Nakamura
Journal:  Biomedicines       Date:  2022-05-02

2.  Influence of Periodontal Ligament Stem Cell-Derived Conditioned Medium on Osteoblasts.

Authors:  Solen Novello; Sylvie Tricot-Doleux; Agnès Novella; Pascal Pellen-Mussi; Sylvie Jeanne
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

3.  Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model.

Authors:  Deniz Genç; Osman Bulut; Burcu Günaydin; Mizgin Göksu; Mert Düzgün; Yelda Dere; Serhat Sezgin; Akın Aladağ; Aziz Bülbül
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

4.  Analysis of circRNAs profile in TNF-α treated DPSC.

Authors:  Qiyin Lei; Zezi Liang; Qiaoling Lei; Fuying Liang; Jing Ma; Zhongdong Wang; Shoudi He
Journal:  BMC Oral Health       Date:  2022-07-03       Impact factor: 3.747

5.  Potentiality and Inflammatory Marker Expression Are Maintained in Dental Pulp Cell Cultures from Carious Teeth.

Authors:  Shelly Arora; Paul R Cooper; Lara T Friedlander; Benedict Seo; Shakila B Rizwan; Alison M Rich; Haizal Mohd Hussaini
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

6.  Dental pulp stem cells-based therapy for the oviduct injury via immunomodulation and angiogenesis in vivo.

Authors:  Lihua Luo; Zhenjie Xing; Xiangyan Liao; Yejian Li; Yu Luo; Yilong Ai; Yan He; Qingsong Ye
Journal:  Cell Prolif       Date:  2022-07-12       Impact factor: 8.755

7.  Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.

Authors:  Ning Li; Lei Li; Mengyao Wu; Yusi Li; Jie Yang; Yicheng Wu; Haimin Xu; Danyang Luo; Yiming Gao; Xiaochun Fei; Liting Jiang
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.